aikifredicist, PPHM has claimed that it worked for solid cancers and can even provide information about the progression of the cancer.
I am not sure but it was either in the PR by which they announced they acquired the world-wide exclusive rights from UTSW or the Q/CC or Annual following it.
I am not sure however about your assessment of the test.
The 10 people WITHOUT cancer can not qualify as 'upfront known'... The test was blinded.
So they may have been told that 44 people where suspected to have ovarian without being given any more info.
What you are saying is that if there would have been 2 liver cancer patients in the 34 and 32 ovarian and 10 healthy the result would have been the same.
That would make this a CANCER vs NO CANCER preliminary test keeping patience from going to plenty of unpleasant and expensive testing and screening if there is no cancer to begin with. That would mean a HUGE LARGE SCALE application ... as such.
Market Data 
Markets 
AI
